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Introduction
Babesiosis is a common tick borne zoonosis with a diverse 
spectrum of severity. Patients most often present with fevers, 
headaches, severe myalgias and nausea. Severe babesiosis 
can be a life threatening condition causing acute respiratory 
distress syndrome, renal failure, cytopenias and disseminated 
intravascular coagulation (DIC) (1,2). The parasite level and 
the severity of the disease do not always correlate. Persistent 
parasitemia has been described in both immunocompetent 
patients with and without treatment and more frequently in 
immunocompromised population (3). Common laboratory 
findings include hemolytic anemia, thrombocytopenia and 
elevated liver enzymes (1,2). However, babesia triggering 
new onset severe immune thrombocytopenia (ITP) has not 
been reported in the literature. Here we present a case of 
a patient with babesiosis and new onset severe ITP despite 
low parasitemia.
Case presentation
A septuagenarian woman with past medical history 
of asthma was transferred to our institution from an 
outside hospital for management of babesiosis and 
thrombocytopenia. A week before admission, she developed 
flu-like symptoms followed by progressive decrease in 
exercise tolerance and dyspnea on exertion. Diffuse rash on 
both her legs prompted her to seek medical evaluation. She 
also reported excessive bruises and ecchymosis following 
blood draws. Review of systems was negative for fever, 
chills, chest pain, weight changes, nausea, abdominal 
pain or vomiting. Her last blood count obtained one year 
earlier was normal. She denied any significant personal or 
family history of bleeding/clotting disorders. In the outside 
hospital babesia organisms were found in the peripheral 
blood smear, with estimated load of 0.5%. Upon admission 
to our hospital the parasite load was 0.3%. She was found 
to have platelet count of 1,000/mcL, LDH 243 IU/L, 
total bilirubin 1.1 mg/dL and haptoglobin 92 mg/dL. On 
physical examination splenomegaly, diffuse petechial rash 
and ecchymoses were present. Peripheral blood smear 
revealed no evidence of thrombotic microangiopathy. 
Platelets auto-antibody was reported as being strongly 
positive. Ehrlichia and Lyme titers were negative. 
Cytomegalovirus and Ebstein-Barr virus antibodies were 
detected in IgG class, but not IgM. She also had negative 
dengue and human immunodeficiency virus serology. 
ADAMTS 13 activity was within normal limits. Abdominal 
ultrasonography revealed hepatosplenomegaly. She was 
initially given intravenous clindamycin and quinine, which 
were later changed to oral atovaquone and azithromycin 
to complete a course of antibiotic therapy for babesiosis. 
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The patient received intravenous immunoglobulin (IVIG) 
for babesiosis-associated ITP. Serial blood smears showed 
clearance of parasitemia. Babesia microti DNA PCR was 
not detected prior to discharge. The patient was discharged 
with platelet count of 104,000/mcL with sustained trend 
upwards. Following discharge the platelet count further 
increased to 169,000/mcL within three days and to 
309,000/mcL within 10 days.
Discussion
Babesia species are intra-erythrocytic parasites. Effective 
cellular response and spleen play a major role in host 
defense against babesiosis. Splenectomy and advancing age 
related decline in cellular immunity are major risk factors 
for severe babesiosis (2,4). Thrombocytopenia is a common 
hematologic finding in tick borne diseases (5). Splenomegaly 
with peripheral destruction of platelets, direct consumption 
and injury to the platelets and marrow suppression are a 
few mechanisms of thrombocytopenia described in the 
literature. Dumler et al. studied bone marrow findings of a 
few patients with human ehrlichiosis and reported findings 
ranging from megakaryocytosis and myeloid hyperplasia 
to pancellular hypoplasia (6). Non-immune mediated 
platelet consumption and destruction leading to diffuse 
intravascular coagulation and thrombotic thrombocytopenia 
purpura have been described in tick borne illnesses like 
ehrlichiosis, babesiosis and rocky mountain spotted fever. 
Autoimmune antibodies were reported in babesiosis and 
ehrlichiosis. Auerbach et al. described hemophagocytosis in 
a case of severe babesiosis which cleared after appropriate 
antibiotic therapy (7). Autoimmune phenomena have also 
been found to be contributory factors for thrombocytopenia 
in tick borne illnesses. Wong et al. used flow cytometry 
to demonstrate presence of anti-platelet antibodies in 
patients with human granulomatous ehrlichiosis (8,9). 
However, in the review of the literature to date, we have 
not found a report of babesiosis causing new onset ITP 
in an otherwise healthy individual. Animal models have 
previously demonstrated immune phenomena against 
platelets in the setting of babesia infection. Lewis et al. 
demonstrated the presence of anti-platelet antibodies in 
the serum of dogs with babesiosis and ehrlichiosis (10,11). 
Orinda et al. reported auto ITP caused by autoantibodies to 
phosphatidyl-serine in cattle infected by babesia bovis (12). 
ITP was also described in a patient with history of Hodgkin 
lymphoma with splenectomy who presented with malaria 
and was diagnosed with babesia divergens infection (13,14). 
It remains unclear whether in this case babesia infection 
triggered the ITP. In the reported by us case, the patient was 
a previously healthy individual. We conclude that ITP was 
most likely triggered by the babesia infection. The severity 
of ITP in this case did not correlate with parasitemia 
which was only 0.3%. Multiple mechanisms of ITP have 
been previously described in the literature (15-18). The 
pathogenetic mechanisms of ITP associated with babesiosis 
remain elusive and require further characterization.
Conclusions
Thrombocytopenia is a common feature of babesiosis. 
ITP could be a probable cause and should be considered 
in patients with new onset severe thrombocytopenia. 
In addition to antibiotics for treatment of babesiosis, 
ITP treatment should be initiated in severe cases. The 
neoantigen triggering the autoimmune response in 
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